---
title: "Chongqing Iron & Steel Updates Investors on Delayed Circular for A-Share Issuance and Whitewash Waiver"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275310588.md"
description: "Chongqing Iron & Steel Co., Ltd. has updated investors on the delayed circular for its proposed A-share issuance and associated whitewash waiver. The company plans to dispatch the circular by February 27, 2026, pending regulatory approval. The issuance and waiver are subject to conditions, including shareholder approval. A mandatory offer may be triggered if the waiver is not granted. Analysts currently rate the stock as a Hold with a price target of HK$1.00. The company operates in the steel industry and has a market cap of HK$14.48B."
datetime: "2026-02-09T11:39:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275310588.md)
  - [en](https://longbridge.com/en/news/275310588.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275310588.md)
---

# Chongqing Iron & Steel Updates Investors on Delayed Circular for A-Share Issuance and Whitewash Waiver

### Valentine's Day Sale - 70% Off

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Chongqing Iron & Steel Co., Ltd. Class H ( (HK:1053) ) has shared an update.

Chongqing Iron & Steel has provided a monthly update on its proposed issuance of new A shares to a specific substantial shareholder, alongside an associated whitewash waiver application under Hong Kong takeover rules. The company is finalising a circular containing group financials and an independent financial adviser’s opinion, which it now expects to dispatch to shareholders on or before 27 February 2026 after obtaining regulatory consent for a delay.

The share issuance and the whitewash waiver remain subject to multiple conditions, including high approval thresholds from independent shareholders at an extraordinary general meeting, and may or may not proceed. An associated mandatory offer would only be triggered if the whitewash waiver is not granted or not approved and the issuance goes ahead, leaving shareholders and potential investors advised to exercise caution as the outcome could significantly affect the company’s capital structure and control dynamics.

The most recent analyst rating on (HK:1053) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Chongqing Iron & Steel Co., Ltd. Class H stock, see the HK:1053 Stock Forecast page.

**More about Chongqing Iron & Steel Co., Ltd. Class H**

Chongqing Iron & Steel Company Limited is a mainland Chinese steel producer based in Chongqing, operating in the iron and steel industry. The company issues both A shares and H shares in Hong Kong, and its shareholder base includes substantial and independent shareholders whose approvals are required for major equity transactions.

**YTD Price Performance:** -0.85%

**Average Trading Volume:** 7,852,851

**Technical Sentiment Signal:** Hold

**Current Market Cap:** HK$14.48B

### Related Stocks

- [515210.CN](https://longbridge.com/en/quote/515210.CN.md)
- [601005.CN](https://longbridge.com/en/quote/601005.CN.md)

## Related News & Research

- [Chongqing Iron & Steel Shareholders Approve All Resolutions, Whitewash Waiver Granted](https://longbridge.com/en/news/279062450.md)
- [Chongqing Iron & Steel Calls EGM to Approve Targeted A-Share Issuance and Dividend Plan](https://longbridge.com/en/news/276709424.md)
- [Conquest Resources Provides Exploration Update at the Valimaki Gold Project, Finland | CQRLF Stock News](https://longbridge.com/en/news/286900378.md)
- [China tightens steel capacity rules as Thyssenkrupp exits US plant](https://longbridge.com/en/news/286786661.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)